Cell surface IgM expression of PGT128/130 gl precursor

RP Ralph Pantophlet
NT Nino Trattnig
SM Sasha Murrell
NL Naiomi Lu
DC Dennis Chau
CR Caitlin Rempel
IW Ian A. Wilson
PK Paul Kosma
request Request a Protocol
ask Ask a question
Favorite

To enable cell surface expression of the predicted PGT128/130 gl antibody precursor20 in its IgM form, the 3′ end of the gene encoding soluble IgM in vector pFUSEss-CHIg-hM*03 (Invivogen) was replaced with that of membrane-bound IgM (mI gM)47 to yield vector pFUSEss-CHIg-mhM*03v2. The VH segment of the gl precursor was then subcloned into the resulting vector using as PCR template a plasmid encoding the heavy chain of the antibody (kindly provided by Dennis Burton). The resulting heavy-chain-expressing plasmid was then mixed with the transfection reagent Fugene HD (ThermoFisher) at a 1:1 ratio with a light-chain expression plasmid (also kindly provided by Dennis Burton) and transfected into mycoplasma-free 293T cells (ATCC; cat. no. CRL-11268). Cells were trypsinized (TrypLE Express; ThermoFisher) 3 days post-transfection, and re-suspended in FACS staining buffer (Hank’s Buffer Staining Solution (HBSS; Lonza) supplemented with 10% (v/v) FBS (Thermo Fisher)). The cells were then incubated with NIT150b, a biotinylated version of the NIT82B glycoconjugate (see above), and then with phycoerythrin-conjugated streptavidin and allophycocyanin-conjugated anti-human F(ab’)2 (both from Jackson ImmunoResearch). All incubation steps were performed for 30 min on ice and samples washed and re-suspended in staining buffer between steps. The data were acquired on a BD FACSJazz and analyzed with FlowJo software (v10; Treestar).

Do you have any questions about this protocol?

Post your question to gather feedback from the community. We will also invite the authors of this article to respond.

post Post a Question
0 Q&A